Key result
Heart failure progression shares multiple molecular signaling pathways with cancer biology, suggesting that targeted therapies addressing specific phenotypic endpoints and molecular checkpoints may offer new treatment strategies.
Answers are grounded in this paper and cite their sources.
Discusses the shared features of organ size, shape, and histological phenotype changes in tumorigenesis and heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hoshijima et al. (2002) conducted a review in Heart failure. Heart failure progression shares multiple molecular signaling pathways with cancer biology, suggesting that targeted therapies addressing specific phenotypic endpoints and molecular checkpoints may offer new treatment strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: